BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

W. L. Gore & Associates, Inc. Prevails in Heart Device Patent Infringement Suit


8/5/2013 8:11:39 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gore Prevails in Heart Device Patent Infringement Suit

FLAGSTAFF, Ariz.--(BUSINESS WIRE)-- W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder. The Hon. Judge Joan Ericksen of the U.S. District Court for the District of Minnesota ruled on July 23, 2013 in Gore’s favor that the GORE HELEX Septal Occluder does not infringe the asserted claims of AGA Medical Corp.’s (AGA) U.S. Patent 5,944,738 (‘738 patent) and granted Gore’s request for summary judgment of non-infringement.*

In August 2010, Gore was sued for patent infringement by AGA, which became part of St. Jude Medical as of November 2010. AGA alleged that the GORE HELEX Septal Occluder infringed some claims of AGA’s ‘738 patent which covers certain transcatheter occlusion products for the treatment of heart defects. AGA sought damages against Gore and a permanent injunction prohibiting Gore from selling the GORE HELEX Septal Occluder both in the United States and abroad.

“The GORE HELEX Septal Occluder has more than 13 years of successful clinical experience for treatment of atrial septal defects and was the first transcatheter device of its kind to use soft expanded polytetrafluoroethylene (ePTFE) patch material with a minimal wire frame,” said Stuart Broyles, PhD, Associate with the Gore Medical Products Division. “We obtained four U.S. Patents related to this innovation (U.S. Patents 5,879,366; 6,080,182; 6,171,329; and 6,623,508). We are happy with Judge Ericksen’s decision and are committed to continue to protect our innovations and invest in innovative medical device products to improve patient outcomes.”

AGA has the right to appeal this decision. Gore is represented by Faegre Baker Daniels, LLP, Minneapolis, MN. AGA is represented by Carlson, Caspers, Vandenburgh, Lindquist & Schuman, P.A., Minneapolis, MN.

ABOUT W. L. GORE & ASSOCIATES

The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac, and general surgery. Gore is one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.

*AGA Medical Corp. v. W. L. Gore & Associates, Inc, Civ. No. 10-3734 (JNE/JSM) (D. Minn.)

GORE®, HELEX®, and designs are trademarks of W. L. Gore & Associates.

Contact:

Chempetitive Group for W. L. Gore & Associates

Kena Hudson or Erik Clausen

510-908-0966

GoreMedical@Chempetitive.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES